United States News All stories

Clorox (NYSE:CLX) declared a quarterly dividend of $1.25 per common share on September 23, 2026, with payment scheduled for November 13, 2026.

Better Home & Finance (NASDAQ:BETR) opened an investigation into allegations that director and former CEO Vishal Garg sought to exchange company interests and property for shareholder consents supporting his proposal to replace the board.

Afya (NASDAQ:AFYA) entered a binding merger agreement with Yduqs Participações S.A. to combine the two Brazilian higher education companies.

AtlasClear Holdings (NYSE:ATCH) reported fiscal 2026 revenue of $20.1 million for the year ended June 30, 2026, representing an 85% increase from the prior year.

Greenland Mines (NASDAQ:GRML) announced more than $42 million in equity financing on September 24, 2026, through a registered direct offering and warrant exercises.

RTX (NYSE:RTX) subsidiary Pratt & Whitney Canada signed a four-year maintenance agreement with AirBorneo Airways covering PW127M engines used on its ATR 72-500 turboprop aircraft.

Jacobs (NYSE:J) will continue supporting thyssenkrupp Steel’s hydrogen-capable direct reduction plant in Duisburg, Germany, through an extended project management and construction services contract.

Novartis (NYSE:NVS) won a lawsuit in Manhattan federal court after a judge dismissed claims that the company improperly used an Entresto patent listing to delay generic competition.

Devon Energy (NYSE:DVN) received a letter from Toms Capital Management urging the company to explore strategic alternatives, including a potential sale of the entire company.

Bio-Techne (NASDAQ:TECH) shareholders approved the proposed acquisition by Merck KGaA, Darmstadt, Germany, at a special meeting held on September 23, 2026.

Immunovant (NASDAQ:IMVT) reported topline results from Period 1 of its proof-of-concept trial of IMVT-1402 in cutaneous lupus erythematosus, with the study failing to meet its primary endpoint.

Oruka Therapeutics (NASDAQ:ORKA) reported positive Week 28 results from the Phase 2a EVERLAST-A trial evaluating ORKA-001 in patients with moderate-to-severe plaque psoriasis.

AC Immune (NASDAQ:ACIU) reported that all primary endpoints were met at week 100 in Part 1 of its Phase 2 VacSYn trial evaluating ACI-7104 in early Parkinson’s disease.

Sharon AI (NASDAQ:SHAZ) is collaborating with VAST Data to offer VAST DataEnclave confidential AI capabilities through its AI Factory platform across Australia and Asia-Pacific.

Cintas (NASDAQ:CTAS) reported fiscal 2027 first-quarter revenue of $3.01 billion, an increase of 10.9% from $2.72 billion in the prior-year period.

Viasat (NASDAQ:VSAT) secured a $42 million initial task order under a seven-year U.S. Marine Corps satellite communications contract announced on September 23, 2026.

SLB (NYSE:SLB) received a contract from OQ Exploration & Production (OQEP) to deliver the Bisat-B Expansion Production Facility in Oman.

HUHUTECH (NASDAQ:HUHU) reported first-half 2026 revenue of $10.67 million, an increase of 8.6% from the prior-year period, supported by contributions from new international operations.

Roivant (NASDAQ:ROIV) reported topline results from Immunovant’s proof-of-concept trial of IMVT-1402 in cutaneous lupus erythematosus, with the study failing to meet its primary endpoint.

IM Cannabis (NASDAQ:IMCC) signed a non-binding letter of intent to acquire 51% of Space Defense Innovations (SDI), a Poland-based company operating in the European unmanned aerial systems market.

Best Buy (NYSE:BBY) and Amazon (NASDAQ:AMZN) expanded their multiyear Fire TV partnership to continue providing Fire TV software on Insignia TVs and introduce new connected TV advertising opportunities.

Blue Moon (NASDAQ:BMM) signed a definitive agreement to acquire the Turner copper-gold VMS deposit in Oregon from Gold Coast Mining through a combination of cash, shares, and milestone payments.

Cracker Barrel (NASDAQ:CBRL) reported fourth-quarter fiscal 2026 revenue of $849.3 million, with higher profitability despite lower sales compared with the prior year.